Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.
Blood. 2019 Feb 7;133(6):540-549. doi: 10.1182/blood-2018-09-876805. Epub 2018 Dec 3.
Blood. 2019.
PMID: 30510079
Free PMC article.
Clinical Trial.
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial.
Lee JW, Griffin M, Kim JS, Lee Lee LW, Piatek C, Nishimura JI, Carrillo Infante C, Jain D, Liu P, Filippov G, Sicre de Fontbrune F, Risitano A, Kulasekararaj AG; ALXN2040-PNH-301 Investigators.
Lee JW, et al.
Lancet Haematol. 2023 Dec;10(12):e955-e965. doi: 10.1016/S2352-3026(23)00315-0.
Lancet Haematol. 2023.
PMID: 38030318
Clinical Trial.
Item in Clipboard
Gene symbol: ALAS2. Disease: sideroblastic anaemia.
Pereira JC, Gutiérrez EO, Ribeiro ML.
Pereira JC, et al. Among authors: gutierrez eo.
Hum Genet. 2004 Nov;115(6):533.
Hum Genet. 2004.
PMID: 15678587
No abstract available.
Item in Clipboard
Cite
Cite